SCHEMBL8488164

SCHEMBL8488164

Cn1cccc1C(=O)[N]c1ccc2c(C(=O)NCc3ccc(C#N)cc3)cccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.44
HDAC4 P56524 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC7 Q8WUI4 2/20 0.44
HDAC2 Q92769 2/20 0.44
HDAC10 Q969S8 2/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
HDAC5 Q9UQL6 2/20 0.44
KLKB1 P03952 2/20 0.42
KLK1 P06870 2/20 0.42
HDAC11 Q96DB2 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
USP2 O75604 2/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
EPHX2 P34913 1/20 0.38
IMPDH2 P12268 1/20 0.37
ELANE P08246 2/20 0.37
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8489621 0.80 EGLN1 (0.46) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8525436 0.75 HDAC2 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1320296 0.75 HDAC2 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8494353 0.74 HDAC2 (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8525059 0.73 HDAC2 (0.46) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8525574 0.72 AKR1B1 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8524189 0.71 AKR1B1 (0.48) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8524730 0.67 CA12 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1110102 0.67 TUBB (0.46) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18678664 0.65 MMP3 (0.54) HDAC1KLKB1KLK1EPHX2ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999029670-A2 AMINOCARBONYLTETRALIN AND DIHYDRONAPHTALENE DERIVATES AS THROMBIN INHIBITORS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-06-17 WO disclosed